loncastuximab tesirine-lpyl 10 MG Injection

RxCUI: 2540969
RxNorm name: loncastuximab tesirine-lpyl 10 MG Injection
Display name: loncastuximab tesirine-lpyl 10 MG Injection
Full name: loncastuximab tesirine-lpyl 10 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761196	Zynlonta	loncastuximab tesirine-lpyl	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZYNLONTA	LONCASTUXIMAB TESIRINE	ADC Therapeutics America, Inc.	af54af12-3edf-4301-8bc5-0446bc813c1d	2026-06-12	Warnings, Adverse reactions	Exact identifier rxcui: 2540969

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
af54af12-3edf-4301-8bc5-0446bc813c1d	loncastuximab tesirine-lpyl 10 MG Injection [PSN] · loncastuximab tesirine-lpyl 10 MG Injection [SCD]	2	14	These highlights do not include all the information needed to use ZYNLONTA safely and effectively. See full prescribing information for ZYNLONTA. ZYNLONTA ® (loncastuximab tesirine-lpyl) for injection, for intravenous use Initial U.S. Approval: 2021	20260226